ShiraTronics develops a neuromodulation device that is implanted beneath the skin to provide continuous stimulation to specific nerves associated with chronic migraine. This technology aims to reduce the frequency and severity of migraine attacks for individuals who do not find relief through traditional medications.
Funding
$111.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+1Founders
Product
Problem
Chronic migraine significantly impacts daily life, making it difficult to concentrate, work, and engage in activities. Many individuals do not find adequate relief from traditional medications, leading to a diminished quality of life.
Solution
ShiraTronics is developing a neuromodulation device designed to provide continuous stimulation to specific nerves associated with chronic migraine. The device is implanted beneath the skin and aims to relieve, interrupt, and potentially prevent chronic migraine symptoms. This technology offers an alternative for individuals who have not found sufficient relief through traditional medication. By targeting the underlying neurological pathways involved in migraine, ShiraTronics seeks to reduce the frequency and severity of migraine attacks, ultimately restoring quality of life.
Target Audience
The primary target audience is individuals experiencing chronic migraine who have not achieved satisfactory relief from traditional medications.
Features
- Implantable neuromodulation device for continuous nerve stimulation
- Targeted stimulation of nerves associated with migraine
- Designed to relieve, interrupt, and potentially prevent chronic migraine symptoms